Search

everythinglearnresearchcommunity

for

Search:↓

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Patients with mycosis fungoides have a higher risk of heart disease.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Obese women with PCOS are more likely to have fatty liver disease.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

DHT may increase the risk of heart disease and death in elderly men.

Platelet-rich plasma therapy may have benefits and is generally safe, but more research is needed to confirm its effectiveness and safety.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Cardiovascular disease deaths decreased but still caused one-third of U.S. deaths in 2007, with high rates of hypertension, smoking, obesity, and diabetes.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

People with Primary Cicatricial Alopecia have a higher risk of heart disease.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

Smoking and alcohol worsen hair transplant results.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.